John L. Villano, MD, PhD

  • Director, Clinical Neuro-Oncology Research Program
  • Medical Director, Precision Medicine Clinic
REQUEST AN APPOINTMENT
Are you a physician?
Refer a Patient

About

John L. Villano specializes in the treatment of brain cancers. He will advance UK HealthCare's Clinical Neuro-Oncology Research Program, serving as its director. UK HealthCare has a history of being a world-class neuro-oncology program, and he will help carry this tradition into the future.

Previously, Dr. Villano served as the director of medical neuro-oncology at the University of Illinois Medical Center. He earned a medical degree and doctor of philosophy at the University of Texas Southwestern Medical School at Dallas and trained in neurology at the University of Michigan. He also completed a fellowship in hematology/oncology at the University of Chicago. He is a former American Society of Clinical Oncology track leader for CNS tumors. Currently, he is on the board of the Central Brain Tumor Registry US. He is also a member of the Neuro-Oncology Committee in the cooperative group ALLIANCE and a Society of Neuro-Oncology committee member.

Faculty Rank

  • Medical Director, Precision Medicine Clinic
  • Professor of Medicine

Training & Education

Degree

University of Texas Southwestern Medical Center, Dallas

Residency

Neurology, University of Michigan Medical School, Ann Arbor
Internal Medicine, Cook County Hospital, Chicago

Fellowship

Hematology/Oncology, University of Chicago

Certifications and Special Training

American Board of Internal Medicine
American Board of Internal Medicine, Medical Oncology

Research

Research Focus

Clinical Trials involved in Neuro-Oncology and in lung cancer. I am also involved in collaborated with the investigators at Kentucky Cancer Registry (KCR) and at Central Brain Tumor Registry of the United States (CBTRUS) to perform descriptive epidemiology studies. We have worked on topics that are less known or investigated, where application of clinical knowledge assists in interpretation of epidemiology data. 

Programs

Translational Oncology

College & Department

Contact Information

800 Rose St.
CC 446
Lexington, KY 40536
United States

Phone
859-323-0405
Email
jlvillano@uky.edu

Publications

  1. Four-jointed is required for intermediate growth in the proximal-distal axis in Drosophila.
    Villano, J.L. and Katz, F.N. (1995) Development. 121:2767-77.
  2. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality.
    Stupp, R., Wong, E.T., Kanner, A.A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E.D., Taillibert, S., Liebermann, F., Dbalý, V., Ram, Z., Villano, J.L., Rainov, N., Weinberg, U., Schiff, D., Kunschner, L., Raizer, J., Honnorat, J., Sloan, A., Malkin, M., Landolfi, J.C., Payer, F., Mehdorn, M., Weil, R.J., Pannullo, S.C., Westphal, M., Smrcka, M., Chin, L., Kostron, H., Hofer, S., Bruce, J., Cosgrove, R., Paleologous, N., Palti, J., Gutin, P.H. (2012) Eur J Cancer. 48(14):2192-202
  3. Incidence of Brain Metastasis at Initial Presentation of Lung Cancer.
    Villano, J.L., Durbin, E.B., Normandeau, C., Thakkar, J.P., Moirangthem, V., Davis, F.G. (2014) Neuro-Oncol. 17(1):122-8
  4. Epidemiology of Meningiomas Post Public Law 107-206 - The Benign Brain Tumor Cancer Registries Amendment Act.
    Dolecek, T.A., Dressler, E.V., Thakkar, J.P., Liu, M., Al-Qaisi, A., Villano, J.L. (2015) Cancer. 121(14):2400-10
  5. Incidence of CNS tumors in Appalachian children.
    Huang, B., Luo, A., Durbin, E.B., Lycan, E., Tucker, T., Chen, Q., Horbinski, C., Villano, J.L. (2017) J Neuro-Oncol. Mar 11. [Epub ahead of print].